Intelligence Feed event · Equity · 2026-09-06

    Intuitive Surgical Navigates 40% Drawdown as MDT and JNJ Challenge da Vinci Share

    Question

    Intuitive Surgical Navigates 40% Drawdown as MDT and JNJ Challenge da Vinci Share

    Direct answer

    Intuitive Surgical is experiencing multiple compression, with the stock down 40% from its post-pandemic highs as capital equipment sales of da Vinci robotic systems decelerate. The slowdown coincides with expanded commercial efforts by Medtronic and Johnson & Johnson to place rival robotic platforms in acute care networks. Despite intensifying competitive bids for new surgical suites, Intuitive Surgical maintains a defensive revenue moat, with recurring parts, consumables, and multi-year service contracts generating 75% of total sales. The shift in hospital capital allocation towards dual-vendor environments will test ISRG procedure volume retention over the medium term.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-06
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Intuitive Surgical Navigates 40% Drawdown as MDT and JNJ Challenge da Vinci Share”, revision 1, evidence through 2026-09-06. https://marketontology.com/market-events/2026-09-06/intuitive-surgical-navigates-40-drawdown-as-mdt-and-jnj-challenge-da-vinci-share-a22b3e

    EQUITY
    Intuitive Surgical Navigates 40% Drawdown as MDT and JNJ Challenge da Vinci Share
    Intuitive Surgical is experiencing multiple compression, with the stock down 40% from its post-pandemic highs as capital equipment sales of da Vinci robotic systems decelerate. The slowdown coincides with expanded commercial efforts by Medtronic and Johnson & Johnson to place rival robotic platforms in acute care networks. Despite intensifying competitive bids for new surgical suites, Intuitive Surgical maintains a defensive revenue moat, with recurring parts, consumables, and multi-year service contracts generating 75% of total sales. The shift in hospital capital allocation towards dual-vendor environments will test ISRG procedure volume retention over the medium term.
    ISRGMDTJNJ
    Impact
    66
    SEP 6
    SIG
    80%
    ISRGMDTJNJ
    Intuitive Surgical Navigates 40% Drawdown as MDT and JNJ Challenge da Vinci Share
    Intuitive Surgical is experiencing multiple compression, with the stock down 40% from its post-pandemic highs as capital equipment sales of da Vinci robotic systems decelerate. The slowdown coincides with expanded commercial efforts by Medtronic and Johnson & Johnson to place rival robotic platforms in acute care networks. Despite intensifying competitive bids for new surgical suites, Intuitive Surgical maintains a defensive revenue moat, with recurring parts, consumables, and multi-year service contracts generating 75% of total sales. The shift in hospital capital allocation towards dual-vendor environments will test ISRG procedure volume retention over the medium term.
    → Competitive market entry by MDT and JNJ compresses ISRG new-system unit margins while installed-base recurring service contracts defend baseline cash flow.
    Impact
    Intuitive Surgical is experiencing multiple compression, with the stock down 40% from its post-pandemic highs as capital equipment sales of da Vinci robotic systems decelerate. The slowdown coincides with expanded commercial efforts by Medtronic and Johnson & Johnson to place rival robotic platforms in acute care networks. Despite intensifying competitive bids for new surgical suites, Intuitive Surgical maintains a defensive revenue moat, with recurring parts, consumables, and multi-year service contracts generating 75% of total sales. The shift in hospital capital allocation towards dual-vendor environments will test ISRG procedure volume retention over the medium term.
    Affected
    ISRGMDTJNJ
    Transmission
    Competitive market entry by MDT and JNJ compresses ISRG new-system unit margins while installed-base recurring service contracts defend baseline cash flow.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    ISRGvaluation multiple compression offset by 75% recurring service revenueMixed1-3mISRG stock down 40% from highs amid da Vinci sales cooling and MDT/JNJ competition.
    MDTsurgical robotics market share acquisition in hospital procurement bidsUp1-3mMedtronic competing directly against da Vinci robot installations.
    JNJmedtech portfolio diversification via surgical robotics deploymentsUp1-3mJohnson & Johnson competing in robotic surgery hardware markets.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    JNJUpdisagreed275.23 2026-09-04-2.22%-3.24%-8.10%

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month